Concomitant use or discontinuation of CYP2D6 inhibitors, CYP3A4 inhibitors or inducers: monitor closely and consider dose adjustments (see full labeling). Withdraw gradually by 25–50% every 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback